Nanoform sets new near-term business target for 2021 and 2022
Insider information Nanoform Finland Plc February 26, 2021 08:05 a.m.…
Additional Positive Interim Results from Nanoform’s Clinical Study
Insider information Nanoform Finland Plc February 24, 2021 08:10 a.m.…
2021 Controlled & Modified Drug Release Virtual Summit
Our Chief Technology Officer, Niklas Sandler, will be presenting at…
Invitation to presentation of Nanoform’s year-end report for 2020 on February 26, 2021
Press release Nanoform Finland Plc February 12, 2021 11:00 a.m.…
Nanoform and Herantis sign Biologics Proof of Concept Agreement
Press release Nanoform Finland Plc February 9th, 2021 08:10 a.m.…